SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-24-010519
Filing Date
2024-03-19
Accepted
2024-03-19 17:25:22
Documents
4
Period of Report
2024-03-19

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 253515
2 formdef14a_001.jpg GRAPHIC 10453
3 proxy_001.jpg GRAPHIC 223146
4 proxy_002.jpg GRAPHIC 172193
  Complete submission text file 0001493152-24-010519.txt   813860
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Filer) CIK: 0001859007 (see all company filings)

IRS No.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41184 | Film No.: 24765108
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)